KTO 360
Natural health product licensed in Canada
- Licence holder
- Designs for Health
- NPN or DIN-HM
- 80101599
- Status
- Active licence
- Licence date
- 9 June 2020
- Revision date
- 12 January 2023
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Rosmarinus officinalis Source : Feuille Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 200 mg | 50 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Huile de Persea gratissima (Avocat), Triglycéride caprylique/caprique, Saveur de beurre, Gomme de Guar partiellement hydrolysée, Saveur de vanille
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Mesures | 1 Tous les jours |
Uses authorised in Canada
Source of (the) essential amino acid(s) (histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, valine) for the maintenance of good health and involved in protein synthesis. Source of (the) non-essential amino acid(s) (alanine, arginine, aspartic acid, glutamic acid, glycine, proline, serine, tyrosine) involved in protein synthesis. To be used with a program of reduced intake of dietary calories and increased physical activity (if possible) to help in weight management. Source of medium-chain fatty acids that support energy production in the body at a cellular level (ATP). Source of Medium-Chain Fatty Acids, which metabolize into ketones, providing the body, including the brain, with an alternative source of energy (ATP). Medium-chain fatty acids metabolize into ketones, which act as an alternative source of cellular energy (ATP) to body tissues, including the brain and muscles.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80101599
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging